Sirius Genomics this week announced that Kamran Alam has been appointed senior director of business development.
Alam brings to Sirius 12 of years experience in the biotech and medical device industry. Before joining Sirius Genomics, Alam held positions at the Center for Drug Research and Development, Angiotech Pharmaceuticals, and AnorMED, where his work focused on executing partnering deals, mergers, acquisitions, and licensing transactions.
"Sirius Genomics is on track with our existing products and looking to grow our pipeline," Chris Wagner, CEO of Sirius Genomics, said in a statement announcing Alam's appointment. Alam's "extensive background in partnering with both global pharmaceutical and medical device companies, as well as experience in building collaborations with academic and translational research centers, will support our commercialization initiatives and product pipeline development."
Stan Lapidus is the founder, president, and CEO of SynapDx, a new company developing diagnostic tests for the early detection of autism. He is a co-founder of Helicos BioSciences, Cytyc, and Exact Sciences.